AOAgnieszka Ołdakowska

Agnieszka Ołdakowska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agnieszka Ołdakowska has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2012
      • Vol. 66  (4) , 651-5

    [Evaluation of antibody response to HPV vaccination in HIV infected girls].

    by Agnieszka Ołdakowska, Magdalena Marczyńska, Sabina Dobosz, Aleksandra Stańska-Perka, Jolanta Popielska, Małgorzata Szczepańska-Putz

    HIV-infected women have an increased prevalence of HPV infections and high risk of cervical cancer. HPV vaccines seem to be a successive method of prevention in immunocompetent women. To evaluate HPV vaccination effectiveness based on the presence of HPV antibodies in HIV infected girls and to establish factors, which influence vaccination effectiveness. Post vaccination antibodies were evaluated in 17 HIV -infected girls who received 3 doses of quadrivalent (types 6/11/16/18) HPV vaccine at the mean age of 11,5 years (range 9-17 yr). HPV antibodies were checked 1 month to 2 years (mean 18 months) after the third vaccine dose by ELISA HPV IgG assay (Dia.Pro Diagnostic Bioprobes). All patients have been receiving combined antiretroviral treatment (cART). Analyzed factors included: age at HIV diagnosis, age at the first vaccine dose, Centers for Disease Control and Prevention (CDC) classification at diagnosis, at vaccination and at evaluation. HPV antibodies were present in all 17 (100%) patients. HIV-infection was diagnosed at the mean age of 3,5 years (range 1 month--10.5 years). Nadir clinical CDC category: 7/17 patients (41%)--A, 5/17 (29,5%)--B, 5/29 (29.5%)--C. Nadir CDC count pointed moderate immunosuppression in 8/17 (47%) children and severe in 9/17 (53%). At vaccination 15/17 girls had CDC classification N1/A1, 2/17 (11.7%) were classified N2. At evaluation all girls had CDC classification N1 or A1. CONCLUSIONS. HPV vaccination in HIV infected girls resulted in successful antibody response. Immune recovery due to cART resulted in a good vaccine response, even in children with prior severe immunodeficiency.


  • Open Access

    Rekomendacje zespołu ekspertów dotyczące stosowania dwudawkowego schematu szczepień przeciw ospie wietrznej

    by Teresa Jackowska, Alicja Chybicka, Hanna Czajka, Anna Dobrzańska, Ewa Duszczyk, Waleria Hryniewicz, Witold Lukas, Magdalena Marczyńska, Agnieszka Ołdakowska, Paweł Stefanoff, et al.


    • 1 January 2010
      • Vol. 64  (2) , 323-8

    [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].

    by Agnieszka Ołdakowska, Magdalena Marczyńska

    To evaluate hepatitis B vaccination effectiveness. 49 vertically HIV-infected children were enrolled. Anti-HBs antibodies were evaluated at HIV diagnosis, at evaluation (year 2004) and after primary vaccination. The following factors were analyzed: age, time since the last vaccine dose, clinical and immunological CDC category, HIV viral load, age at the beginning of ART. At HIV diagnosis 14% of children had anti-HBs antibody level > or = 100 mLU/ml. At evaluation 76% of patients had anti-HBs antibody level > or = 100 mIU/ml. Children, who were diagnosed before their first birthday, were more likely to have protective antibody level (p < 0.01). Percentage of lymphocyte T CD4+ count (p < 0.01) and time since last vaccination (p < 0.01) were found to be important factors of vaccination response. Primary vaccination was effective in 86% of children. Factors which influenced vaccination effectiveness included early HIV diagnosis, percentage of lymphocyte T CD4+ at evaluation and time since last vaccination. The effectiveness of primary vaccination was high.

  • Open Access

    A suspicion of aspergillosis in a child with AIDS – a case report

    by Agnieszka Ołdakowska, Sabina Dobosz, Małgorzata Szczepańska-Putz, Magdalena Marczyńska

    • 8 May 2009
      • Vol. 12  (2)

    [Measles vaccination in HIV infected children].

    by Agnieszka Ołdakowska, Magdalena Marczyńska

    Vaccination is one of very important aspects in medical care of HIV infected children.


  • Open Access

    Vertical transmission of Hepatitis C Virus in children born to HIV/HCV coinfected mothers in Poland

    by Sabina Dobosz, Magdalena Marczynska, Agnieszka Oldakowska, Malgorzata Szczepanska-Putz, Konrad Zawadka

    • 13 July 2007
      • Vol. 11  (2)

    [HIV infection in children in Poland - clinical advancement at time of diagnosis].

    by Sabina Dobosz, Magdalena Marczyńska, Małgorzata Szczepańska-Putz, Jolanta Popielska, Agnieszka Ołdakowska

    At the end of 2006, there were about 130 children with confirmed HIV infection in Poland, 90% of them being infected vertically.

    • 1 January 2007
      • Vol. 61  (2) , 363-9

    [20-years experiences of HIV infected children's care].

    by Magdalena Marczyńska, Jolanta Popielska, Małgorzata Szczepańska-Putz, Sabina Dobosz, Agnieszka Ołdakowska

    The aim was to present the 20-years experiences of medical care of children borne to HIV(+) mothers and HIV infected children. Between 1987 and 2006 year 305 children borne to HIV(+) mother were investigated. The risk of vertical transmission was estimated. We analyzed routs of HIV transmission, the reasons of HIV diagnosis, HIV staging at diagnosis, HBV and HCV coinfection, ART treatment and its efficacy. HIV infection was confirmed: 75 cases of vertical HIV infection and 8 children infected in other ways. 260 children were borne after 1994 year (the date of introducing recommendation of the use of ART to reduce perinatal transmission of HIV). 158 of them received prophylaxis of vertical HIV infection. The risk of HIV vertical in children receiving prophylaxis was 5% comparing to 45.6% risk in children without prophylaxis regimens. 66 children receive ART regimen. The efficacy of treatment was: viral 85%, immunological: 89% and clinical: 85% improvement. HIV testing should be offered to every women in the child-bearing age. Current prophylaxis, which suppress maternal VL HIV below detection level, decrease the risk of vertical HIV transmission to 0-1%. The child born to HIV(+) mother requires early diagnostics of HIV, HBV, HCV infections. Because of rapid progression of the disease, the HIV infected child should be diagnosed and treated since the first year of life. Properly treated children reach to mature age.